Literature DB >> 16096406

NF1-associated gastrointestinal stromal tumors have unique clinical, phenotypic, and genotypic characteristics.

Johanna Andersson1, Harri Sihto, Jeanne M Meis-Kindblom, Heikki Joensuu, Nina Nupponen, Lars-Gunnar Kindblom.   

Abstract

Gastrointestinal stromal tumors (GIST) have been reported to occasionally occur in patients with neurofibromatosis type 1 (NF1). This study aims to describe the phenotypic and genotypic characteristics of GIST in NF1 patients and attempts to elucidate the relationship between them. We analyzed GIST arising in 15 NF1 patients (8 males and 7 females, 19-82 years of age). Eleven patients had multiple GISTs (3 to >100 tumors) ranging from 1 mm to 10 cm in size and predominantly involving the small intestine including the duodenum. Tumors were symptomatic in 8 patients and incidental findings in the remaining 7 patients. Microscopically, the tumors cells were typically spindled and the mitotic rate low; 9 patients had tumors classified as very low or low risk and 6 as intermediate risk GIST. Nine patients were treated surgically and none developed metastases or died of disease. Immunohistochemical stains for CD117 were strongly positive in 47 of 50 GIST; they also accentuated hyperplastic foci (diffuse and focal) of the interstitial cells of Cajal that were often associated with microscopic GIST in the surrounding intestinal muscle wall. No KIT or PDGFRA mutations were detected in 24 GIST from 12 patients using dHPLC analysis and DNA sequencing. We conclude that patients with NF1 have a high risk of developing GIST. NF1-associated GIST are also phenotypically and genotypically distinct from sporadic GIST, indicating that different pathogenetic mechanisms are involved in their evolution.

Entities:  

Mesh:

Year:  2005        PMID: 16096406     DOI: 10.1097/01.pas.0000159775.77912.15

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  76 in total

1.  Perioperative management of neurofibromatosis type 1.

Authors:  Charles J Fox; Samir Tomajian; Aaron J Kaye; Stephanie Russo; Jacqueline Volpi Abadie; Alan D Kaye
Journal:  Ochsner J       Date:  2012

2.  Relationship between gene mutations and protein expressions of PDGFR α and C-kit in gastrointestinal stromal tumors.

Authors:  Jun-Yi He; H X Tong; Y Zhang; J Y Wang; Y B Shao; J Zhu; Wei-Qi Lu
Journal:  Int J Clin Exp Med       Date:  2015-05-15

Review 3.  Histopathology of gastrointestinal stromal tumor.

Authors:  Markku Miettinen; Jerzy Lasota
Journal:  J Surg Oncol       Date:  2011-12       Impact factor: 3.454

4.  Sporadic Cajal cell hyperplasia is common in resection specimens for distal oesophageal carcinoma. A retrospective review of 77 consecutive surgical resection specimens.

Authors:  Abbas Agaimy; Peter H Wünsch
Journal:  Virchows Arch       Date:  2005-11-25       Impact factor: 4.064

5.  Lymphomatoid granulomatosis in a patient previously diagnosed with a gastrointestinal stromal tumour and treated with imatinib.

Authors:  Nabeel Salmons; Richard J Gregg; Anna Pallalau; Ian Woolhouse; Ian Geh; Philippe Tanière
Journal:  J Clin Pathol       Date:  2007-02       Impact factor: 3.411

Review 6.  Tailored management of primary gastrointestinal stromal tumors.

Authors:  Mark S Etherington; Ronald P DeMatteo
Journal:  Cancer       Date:  2019-04-01       Impact factor: 6.860

7.  [Surgical considerations for gastrointestinal stroma tumor].

Authors:  P Hohenberger; E Wardelmann
Journal:  Chirurg       Date:  2006-01       Impact factor: 0.955

8.  Neurofibromin C terminus-specific antibody (clone NFC) is a valuable tool for the identification of NF1-inactivated GISTs.

Authors:  Sabrina Rossi; Daniela Gasparotto; Matilde Cacciatore; Marta Sbaraglia; Alessia Mondello; Maurizio Polano; Alessandra Mandolesi; Alessandro Gronchi; David E Reuss; Andreas von Deimling; Roberta Maestro; Angelo Paolo Dei Tos
Journal:  Mod Pathol       Date:  2017-09-01       Impact factor: 7.842

9.  Diagnostic challenges of motility disorders: optimal detection of CD117+ interstitial cells of Cajal.

Authors:  Megan M Garrity; Simon J Gibbons; Thomas C Smyrk; Jean Marie Vanderwinden; Pedro Julian Gomez-Pinilla; Anoop Nehra; Matthew Borg; Gianrico Farrugia
Journal:  Histopathology       Date:  2009-02       Impact factor: 5.087

10.  A gastrointestinal stromal tumor in a patient with multiple endocrine neoplasia type 2A and metastatic medullary thyroid cancer to the ovaries.

Authors:  Rana Malek; Desiree McCarthy-Keith; Eric D Levens; Maria J Merino; Alan H DeCherney; Lee S Weinstein
Journal:  Endocr Pract       Date:  2008-10       Impact factor: 3.443

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.